These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 20146103)
1. Clinical implication and mitotic effect of CD44 cleavage in relation to osteopontin/CD44 interaction and dysregulated cell cycle protein in gastrointestinal stromal tumor. Hsu KH; Tsai HW; Lin PW; Hsu YS; Shan YS; Lu PJ Ann Surg Oncol; 2010 Aug; 17(8):2199-212. PubMed ID: 20146103 [TBL] [Abstract][Full Text] [Related]
2. Osteopontin expression is an independent adverse prognostic factor in resectable gastrointestinal stromal tumor and its interaction with CD44 promotes tumor proliferation. Hsu KH; Tsai HW; Lin PW; Hsu YS; Shan YS; Lu PJ Ann Surg Oncol; 2010 Nov; 17(11):3043-52. PubMed ID: 20549562 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade. Nakamura N; Yamamoto H; Yao T; Oda Y; Nishiyama K; Imamura M; Yamada T; Nawata H; Tsuneyoshi M Hum Pathol; 2005 Jul; 36(7):828-37. PubMed ID: 16084954 [TBL] [Abstract][Full Text] [Related]
4. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells. Lee JL; Wang MJ; Sudhir PR; Chen GD; Chi CW; Chen JY Cancer Res; 2007 Mar; 67(5):2089-97. PubMed ID: 17332338 [TBL] [Abstract][Full Text] [Related]
5. [Expression and clinical significance of p27 protein and cyclinD1 protein in gastrointestinal stromal tumors]. Yang XD; Zuo M; Pan K Zhonghua Yi Xue Za Zhi; 2005 May; 85(19):1352-4. PubMed ID: 16029637 [TBL] [Abstract][Full Text] [Related]
6. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease. Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358 [TBL] [Abstract][Full Text] [Related]
7. Osteopontin combined with CD44, a novel prognostic biomarker for patients with hepatocellular carcinoma undergoing curative resection. Yang GH; Fan J; Xu Y; Qiu SJ; Yang XR; Shi GM; Wu B; Dai Z; Liu YK; Tang ZY; Zhou J Oncologist; 2008 Nov; 13(11):1155-65. PubMed ID: 18997126 [TBL] [Abstract][Full Text] [Related]
8. [Over-expression of osteopontin in non-small cell lung cancers: its clinical significance]. Hu Z; Xiao T; Lin DM; Guo SP; Zhang ZQ; Di XB; Cheng SJ; Gao YN Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):591-5. PubMed ID: 18210878 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of osteopontin expression in human gastric carcinoma. Higashiyama M; Ito T; Tanaka E; Shimada Y Ann Surg Oncol; 2007 Dec; 14(12):3419-27. PubMed ID: 17896150 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. Rudland PS; Platt-Higgins A; El-Tanani M; De Silva Rudland S; Barraclough R; Winstanley JH; Howitt R; West CR Cancer Res; 2002 Jun; 62(12):3417-27. PubMed ID: 12067984 [TBL] [Abstract][Full Text] [Related]
11. Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin. Zhu B; Suzuki K; Goldberg HA; Rittling SR; Denhardt DT; McCulloch CA; Sodek J J Cell Physiol; 2004 Jan; 198(1):155-67. PubMed ID: 14584055 [TBL] [Abstract][Full Text] [Related]
12. Role of osteopontin and CD44s expression for patients with hepatocellular carcinoma undergoing liver transplantation or resection. Beckebaum S; Chen X; Sotiropoulos GC; Radtke A; Daoudaki M; Baba HA; Wohlschlaeger J; Broelsch CE; Gerken G; Cicinnati VR Transplant Proc; 2008 Nov; 40(9):3182-4. PubMed ID: 19010227 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma. Pan HW; Ou YH; Peng SY; Liu SH; Lai PL; Lee PH; Sheu JC; Chen CL; Hsu HC Cancer; 2003 Jul; 98(1):119-27. PubMed ID: 12833464 [TBL] [Abstract][Full Text] [Related]
14. Prognostic stratification of high-risk gastrointestinal stromal tumors in the era of targeted therapy. Keun Park C; Lee EJ; Kim M; Lim HY; Choi DI; Noh JH; Sohn TS; Kim S; Kim MJ; Lee HK; Kim KM Ann Surg; 2008 Jun; 247(6):1011-8. PubMed ID: 18520229 [TBL] [Abstract][Full Text] [Related]
15. Differential regulation of osteopontin receptors, CD44 and the alpha(v) and beta(3) integrin subunits, in the rat hippocampus following transient forebrain ischemia. Kang WS; Choi JS; Shin YJ; Kim HY; Cha JH; Lee JY; Chun MH; Lee MY Brain Res; 2008 Sep; 1228():208-16. PubMed ID: 18638458 [TBL] [Abstract][Full Text] [Related]
18. Anti-apoptotic effects of osteopontin through the up-regulation of Mcl-1 in gastrointestinal stromal tumors. Hsu KH; Tsai HW; Lin PW; Hsu YS; Lu PJ; Shan YS World J Surg Oncol; 2014 Jun; 12():189. PubMed ID: 24947165 [TBL] [Abstract][Full Text] [Related]
19. Involvement of osteopontin and its signaling molecule CD44 in clinicopathological features of adult T cell leukemia. Chagan-Yasutan H; Tsukasaki K; Takahashi Y; Oguma S; Harigae H; Ishii N; Zhang J; Fukumoto M; Hattori T Leuk Res; 2011 Nov; 35(11):1484-90. PubMed ID: 21645921 [TBL] [Abstract][Full Text] [Related]
20. Reciprocal interactions between tumor-associated macrophages and CD44-positive cancer cells via osteopontin/CD44 promote tumorigenicity in colorectal cancer. Rao G; Wang H; Li B; Huang L; Xue D; Wang X; Jin H; Wang J; Zhu Y; Lu Y; Du L; Chen Q Clin Cancer Res; 2013 Feb; 19(4):785-97. PubMed ID: 23251004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]